Day: February 27, 2026
FRO – Fourth Quarter and Full Year 2025 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy
Written by Customer Service on . Posted in Public Companies.
13/2026・Trifork Group: 2025 annual report and interim report for the quarter ending 31 December 2025
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Lassila & Tikanoja Plc Financial Statements Release January – December 2025
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Luotea’s Financial Statements Release 2025: The partial demerger was completed at year end; significant profitability improvement in continuing operations in 2025
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%)
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
15/2026・Trifork Group: Initiation of share buyback program
Written by Customer Service on . Posted in Public Companies.
14/2026・Trifork Group: Changes to the Board of Directors
Written by Customer Service on . Posted in Public Companies.
Lassila & Tikanoja Plc to launch a share repurchase programme for share‑based incentive schemes and remuneration of the Board of Directors
Written by Customer Service on . Posted in Public Companies.
